Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;11 Suppl 3(Suppl 3):S19.
doi: 10.1186/bcr2438. Epub 2009 Dec 18.

Breast screening has increased the number of mastectomies

J Michael Dixon  1
Affiliations

Breast screening has increased the number of mastectomies

J Michael Dixon. Breast Cancer Res. 2009.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients diagnosed with ductal carcinoma in situ through the UK National Breast Screening Programme. Note in 1998/99 and in 1999/2000 the number of patients includes ductal carcinoma in situ (DCIS) and microinvasive cancers. Data provided by Gill Lawrence and her team at the West Midlands Cancer Intelligence Unit.
Figure 2
Figure 2
Patients diagnosed with with ductal carcinoma in situ treated by mastectomy or breast-conserving surgery. Percentage of patients diagnosed with ductal carcinoma in situ (DCIS) through the UK National Breast Screening Programme treated by mastectomy or breast-conserving surgery (BCS). Note in 1998/99 and in 1999/2000 the percentage of patients includes DCIS and microinvasive cancers. Data provided by Gill Lawrence and her team at the West Midlands Cancer Intelligence Unit.
Figure 3
Figure 3
Patients diagnosed with ductal carcinoma in situ treated by mastectomy. Absolute numbers of patients diagnosed with ductal carcinoma in situ (DCIS) through the UK National Breast Screening Programme treated by mastectomy. Note in 1998/99 and in 1999/2000 the number of patients includes DCIS and microinvasive cancers. Data provided by Gill Lawrence and her team at the West Midlands Cancer Intelligence Unit.
See this image and copyright information in PMC

References

    1. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman P. Consensus Conference Committee. The consensus conference on the treatment of in situ ductal carcinoma of the breast, 22-25 April 1999. Cancer. 2000;88:946–954. doi: 10.1002/(SICI)1097-0142(20000215)88:4<946::AID-CNCR26>3.0.CO;2-5. - DOI - PubMed
    1. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76:1197–1200. doi: 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0. - DOI - PubMed
    1. Yen MF, Tabár L, Vitak B, Smith RA, Chen HH, Duffy SW. Quantifying the potential problem of over diagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer. 2003;39:1746–1754. doi: 10.1016/S0959-8049(03)00260-0. - DOI - PubMed
    1. Barnes NLP, Bundred NJ. In: A Companion to Specialist Surgical Practice: Breast Surgery. Dixon JM, editor. Edinburgh: Saunders; 2009. Treatment of ductal carcinoma in situ; pp. 175–192.
    1. Boland GP, Knox WF, Bundred NJ. Molecular markers and therapeutic targets in ductal carcinoma in situ. Microsc Res Tech. 2002;59:3–11. doi: 10.1002/jemt.10172. - DOI - PubMed